Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
Nature. 2022 Mar;603(7899):124-130. doi: 10.1038/s41586-022-04424-7. Epub 2022 Feb 23.
Nature. 2022.
PMID: 35197626
Free PMC article.
Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2.
Kim G, Nakayama L, Blum JA, Akiyama T, Boeynaems S, Chakraborty M, Couthouis J, Tassoni-Tsuchida E, Rodriguez CM, Bassik MC, Gitler AD.
Kim G, et al.
Cell Rep. 2022 Oct 25;41(4):111508. doi: 10.1016/j.celrep.2022.111508.
Cell Rep. 2022.
PMID: 36288714
Free PMC article.
Item in Clipboard
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Rodriguez CM, Bechek SC, Jones GL, Nakayama L, Akiyama T, Kim G, Solow-Cordero DE, Strittmatter SM, Gitler AD.
Rodriguez CM, et al.
Cell Rep. 2022 Oct 25;41(4):111505. doi: 10.1016/j.celrep.2022.111505.
Cell Rep. 2022.
PMID: 36288715
Free PMC article.
Item in Clipboard
CGG repeats trigger translational frameshifts that generate aggregation-prone chimeric proteins.
Wright SE, Rodriguez CM, Monroe J, Xing J, Krans A, Flores BN, Barsur V, Ivanova MI, Koutmou KS, Barmada SJ, Todd PK.
Wright SE, et al.
Nucleic Acids Res. 2022 Aug 26;50(15):8674-8689. doi: 10.1093/nar/gkac626.
Nucleic Acids Res. 2022.
PMID: 35904811
Free PMC article.
Item in Clipboard
Cite
Cite